Evidence for opponent-process actions of intravenous cocaine

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 3, 1999, Pages 507-512

  Ettenberg, Aaron ^a   Raven, Mary A ^a   Danluck, Deborah A ^a   Necessary, Brian D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Cocaine; Conditioned aversions; Conditioned place preference; Drug reward; Opponent process theory; Stimulant drugs

Indexed keywords

COCAINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONDITIONING; CONFLICT; CONTROLLED STUDY; DRUG EFFECT; ENVIRONMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD;

AGGRESSION; ANIMALS; COCAINE; CONDITIONING, OPERANT; CONFLICT (PSYCHOLOGY); DOPAMINE UPTAKE INHIBITORS; INJECTIONS, INTRAVENOUS; MALE; MODELS, PSYCHOLOGICAL; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); TIME FACTORS;

ANIMALIA;

EID: 0032848259     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00109-4     Document Type: Article

References (58)

1. Anthony J.C., Tein A.Y., Petronis K.R. Epidemiological evidence on cocaine use and panic attacks. Am. J. Epidemiol. 129:1989;543-549.
2. Baker T.B., Morse E., Sherman J.E. The motivation to use drugs. A psychobiological analysis of urges Nebraska Symp. Motivat. 34:1986;257-323.
3. Barr G.A., Paredes W., Bridger W.H. Place conditioning with morphine and phencyclidine. Dose-dependent effects Life Sci. 36:1985;363-368.
4. Booze R.M., Lehner A.F., Wallace D.R., Welch M.A., Mactutus C.F. Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized freely moving male rats. Neurotoxicol. Teratol. 19:1997;7-15.
5. Carr G.D., Fibiger H.C., Phillips A.G. Conditioned place preference as a measure of drug reward. Liebman J.M., Cooper S.J. The neuropharmacological basis of reward. 1989;264-319 Clarendon Press, Oxford.
6. Carroll M.E., Lac S.T. Acquisition of IV amphetamine and cocaine self-administration in rats as a function of dose. Psychopharmacology (Berlin). 129:1997;206-214.
7. Clouet D., Asghar K., Brown R. Mechanisms of cocaine abuse and toxicity. NIDA Research Monograph 88. 1988;U.S. Department of Health & Human Services, Rockville, MD.
8. Costall B., Kelly M.E., Naylor R.J., Onaivi E.S. The actions of nicotine and cocaine in an animal model of anxiety. Pharmacol. Biochem. Behav. 33:1989;197-209.
9. DeVries A.C., Pert A. Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by corticotropin-releasing factor. Psychopharmacology (Berlin). 137:1998;333-340.
10. Duvauchelle C.L., MacConell L.A., Eremia A.D., Ettenberg A. Pimozide prevents the development of conditioned place preferences induced by rewarding locus coeruleus stimulation. Behav. Brain Res. 50:1992;85-92.
11. Erb S., Shaham Y., Stewart J. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J. Neurosci. 18:1998;5529-5536.
12. Ettenberg A., Geist T.D. Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology (Berlin). 103:1991;455-461.
13. Ettenberg A., Geist T.D. Qualitative and quantitative differences in the operant runway behavior of cocaine and heroin reinforced rats. Pharmacol. Biochem. Behav. 44:1993;191-198.
14. Ettenberg A., Pettit H.O., Bloom F.E., Koob G.F. Heroin and cocaine intravenous self-administration in rats. Mediation by separate neural systems Psychopharmacology (Berlin). 78:1982;204-209.
15. Ettenberg A., van der Kooy D., Le Moal M., Koob G.F., Bloom F.E. Can aversive properties of (peripherally-injected) vasopressin account for its putative roles in memory? Behav. Brain Res. 7:1983;331-350.
16. Fibiger H.C., Phillips A.G., Brown E.E. The neurobiology of cocaine-induced reinforcement. Ciba Found. Symp. 166:1992;96-111.
17. Fontana D.J., Commissaris R.L. Effects of cocaine on conflict behavior in the rat. Life Sci. 45:1989;819-827.
18. Geist T.D., Ettenberg A. Concurrent positive and negative goal box events produce runway behaviors comparable to those of cocaine-reinforced rats. Pharamcol. Biochem. Behav. 57:1997;145-150.
19. Goeders N.E. Cocaine differentially affects benzodiazepine receptors in discrete regions of the rat brain. Persistence and potential mechanisms mediating these effects J. Pharmacol. Exp. Ther. 259:1991;574-581.
20. Goeders N.E. A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology. 22:1997;237-259.
21. Hamner M.B. PTSD and cocaine abuse. Hosp. Comm. Psychiatry. 44:1993;591-592.
22. Heinrichs S.C., Klaassen A., Koob G.F., Schulteis G., Ahmed S., De Souza E.B. Corticotropin-releasing factor receptor blockade enhances conditioned aversive properties of cocaine in rats. Psychopharmacology (Berlin). 136:1998;247-255.
23. Koob G.F., Stinus L., Le Moal M., Bloom F.E. Opponent-process theory of motivation. Neurobiological evidence from studies of opiate dependence Neurosci. Biobehav. Rev. 13:1989;135-140.
24. Koob G.F., Caine S.B., Parsons L., Markou A., Weiss F. Opponent process model and psychostimulant addiction. Pharamcol. Biochem. Behav. 57:1997;513-521.
25. Koob G.F., Weiss F. Neuropharmacology of cocaine and ethanol dependence. Rec. Dev. Alcohol. 10:1992;201-323.
26. Ma F., Falk J.L., Lau C.E. Within-subject variability in cocaine pharmacokinetics and pharmacodynamics after intraperitoneal compared with intravenous cocaine administration. Exp. Clin. Psychopharmacol. 7:1999;3-12.
27. Mantsch J.R., Goeders N.E. Generalization of a restraint-induced discriminative stimulus to cocaine in rats. Psychopharmacology (Berlin). 135:1998;423-426.
28. Miller R.L., Baum M.J. Naloxone inhibits matings and conditioned place preferences for an estrous female in male rats soon after castration. Pharmacol. Biochem. Behav. 26:1987;781-789.
29. Moldow R.L., Fischman A.J. Cocaine induced secretion of ACTH, beta-endorphin and corticosterone. Peptides. 8:1987;819-822.
30. Nikolic C.H., Jovanovic M., Mirkovic L. Syndrome PBC. Base cocaine paste abuse (translated title) Psihijatrija-Danas. 16:1984;55-63.
31. Phillips A.G., Blaha C.D., Fibiger H.C. Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses. Neurosci. Biobehav. Rev. 13:1989;99-104.
32. Resnick R.B., Resnick E.B. Cocaine abuse and its treatment. Psychiatr. Clin. North Am. 7:1984;713-728.
33. Rivier C., Vale W. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin releasing factor (CRF)-mediated mechanism. Brain Res. 422:1987;403-406.
34. Roberts D.C. Neural substrates mediating cocaine reinforcement. The role of monoamine systems Lakoski J.M., Galloway M.P., White S.J. Cocaine. Pharmacology, Physiology and clinical strategies:1992;73-90 CRC Press, Boca Raton, FL.
35. Roberts D.C.S., Koob G.F., Klonoff P., Fibiger H.C. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12:1980;781-787.
36. Rogerio R., Takahashi R.N. Anxiogenic properties of cocaine in the rat elevated plus-maze. Pharmacol. Biochem. Behav. 43:1992;631-633.
37. Roselli M., Ardila A. Cognitive effects of cocaine and polydrug abuse. J. Clin. Exp. Neuropsychol. 18:1996;122-135.
38. Sarnyai Z. Neurobiology of stress and cocaine addiction. Studies on corticotropin-releasing factor in rats, monkeys and humans Proc. N.Y. Acad. Sci. 851:1998;371-387.
39. Schechter M.D., Calcagnetti D.J. Trends in place conditioning with a cross-indexed bibliography. 1957-1991 Neurosci. Biobehav. Rev. 17:1993;21-41.
40. Simon P., Dupuis R., Costentin J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions Behav. Brain Res. 61:1994;59-64.
41. Smith D.E. Cocaine-alcohol abuse. Epidemiological, diagnostic and treatment considerations J. Psychoact. Drugs. 18:1986;117-129.
42. Solomon R.L. An opponent-process theory of motivation. IV. The affective dynamics of addiction Maser J.D., Seligman M.E.P. Psychopathology. Experimental models:1977;124-145 Freeman, San Francisco.
43. Solomon R.L. The opponent-process theory of acquired motivation. The costs of pleasure and the benefits of pain Am. Psychol. 35:1980;691-712.
44. Solomon R.L., Corbit J.D. An opponent-process theory of motivation. II. Cigarette addiction J. Abnorm. Psychol. 81:1973;158-171.
45. Solomon R.L., Corbit J.D. An opponent-process theory of motivation. I Temporal dynamics of affect Psychol. Rev. 81:1974;119-145.
46. Spotts J.V., Shontz F.C. Drug-induced ego states. 1. Cocaine: phenomenology and implications Int. J. Addict. 19:1984;119-151.
47. Spyraki C., Fibiger H.C., Phillips A.G. Attenuation by haloperidol of place preference conditioning using food reinforcement. Psychopharmacology (Berlin). 77:1982;379-382.
48. Stewart J., de Wit H., Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol. Rev. 91:1984;251-268.
49. Swerdlow N.R., van der Kooy D., Koob G.F., Wenger J.R. Cholecystokinin produces conditioned place aversions, not place preferences, in food-deprived rats. Evidence against an involvement in satiety Life Sci. 32:1983;2087-2093.
50. Volkow N.D., Ding Y.S., Fowler J.S., Wang G.J., Logan J., Gatley J.S., Dewey S., Ashby C., Liebermann J., Hitzemann R. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch. Gen. Psychiatry. 52:1995;456-463.
51. Wagner J.A., Katz R.J. Anxiogenic action of benzodiazepine antagonists RO 15-1788 and CGS 8216 in the rat. Neurosci. Lett. 48:1984;317-320.
52. Washton A.M., Gold M.S. Chronic cocaine abuse. Evidence for adverse effects on health and functioning Psychiatr. Ann. 14:1984;733-743.
53. White N.M., Carr G.D. The conditioned place preference is affected by two independent reinforcement processes. Pharmacol. Biochem. Behav. 23:1985;37-42.
54. Williamson S., Gossop M., Powis B., Griffiths P., Fountain J., Strang J. Adverse effects of stimulant drugs in a community of drug uses. Drug Alcohol Depend. 44:1997;87-94.
55. Wise R.A. Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 19:1996;319-340.
56. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
57. Yang X.M., Gorman A.L., Dunn A.J., Goeders N.E. Anxiogenic effects of acute and chronic cocaine administration. Neurochemical and behavioral studies Pharmacol. Biochem. Behav. 41:1992;643-650.
58. Young A.M., Herling S. Drugs as reinforcers. Studies in laboratory animals Goldberg S.R., Stolerman I.P. Behavioral analysis of drug dependence. 1986;9-67 Academic Press, New York.